Sonia Serrano

Phase I/II open-label trial of intravenous allogeneic mesenchymal stromal cell therapy in adults with recessive dystrophic epidermolysis bullosa

Ellie Rashidghamat, Tendai Kadiyirire, Salma Ayis et al. · Journal of the American Academy of Dermatology · 2019 · 112 citations · Full text

Medicine, Clinical Sciences, Dermatology +14

Safety and early efficacy outcomes for lentiviral fibroblast gene therapy in recessive dystrophic epidermolysis bullosa

Su M. Lwin, Farhatullah Syed, Wei‐Li Di et al. · JCI Insight · 2019 · 90 citations · Full text

Medicine, Dermatology, Pathology +14

Inhibition of mitotic kinase Mps1 promotes cell death in neuroblastoma

Sonia Serrano, Wondossen Sime, Yasmin Abassi et al. · Scientific Reports · 2020 · 37 citations · Full text

Life Sciences, Cell Biology, Oncology +17

Evaluation of NV556, a Novel Cyclophilin Inhibitor, as a Potential Antifibrotic Compound for Liver Fibrosis

Sonia Serrano, Alvar Grönberg, Lisa Longato et al. · Cells · 2019 · 21 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Cyclophilin Inhibitor NV556 Reduces Fibrosis and Hepatocellular Carcinoma Development in Mice With Non-Alcoholic Steatohepatitis

Joseph Kuo, Sonia Serrano, Alvar Grönberg et al. · Frontiers in Pharmacology · 2019 · 20 citations · Full text

Medicine, Oncology, Pharmacology +8